Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2168  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Detection rate of prostate cancer using prostate specific antigen in patients presenting with lower urinary tract symptoms: A retrospective study

Chavan P R, Chavan S V, Chavan N R, Trivedi V D

Year : 2009| Volume: 55| Issue : 1 | Page no: 17-21

   This article has been cited by
 
1 Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study
Alexandre Peltier,Fouad Aoun,Vincent De Ruyter,Patrick Cabri,Roland Van Velthoven
Prostate Cancer. 2015; 2015: 1
[Pubmed]  [Google Scholar] [DOI]
2 Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10?ng/mL and non-suspicious digital rectal examination
Masaya Ito,Hitoshi Masuda,Satoru Kawakami,Yasuhisa Fujii,Fumitaka Koga,Kazutaka Saito,Shinya Yamamoto,Junji Yonese,Iwao Fukui,Kazunori Kihara
International Journal of Urology. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
3 Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?
Oh, J.J. and Jeong, S.J. and Jeong, C.W. and Byun, S.-S. and Hong, S.K. and Choe, G. and Lee, S.E.
Prostate. 2013; 73(1): 42-47
[Pubmed]  [Google Scholar]
4 Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?
Jong Jin Oh, Seong Jin Jeong, Chang Wook Jeong, Seok-Soo Byun, Sung Kyu Hong, Gheeyoung Choe, Sang Eun Lee
The Prostate. 2012; : n/a
[HTML Full text]  [Google Scholar] [DOI]
5 Is there an optimal prostate-specific antigen threshold for prostate biopsy?
Carsten Stephan, Kurt Miller, Klaus Jung
Expert Review of Anticancer Therapy. 2011; 11(8): 1215
[HTML Full text]  [Google Scholar] [DOI]
6 A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml
Chavan, S.V. and Chavan, N.R. and Balaji, A. and Trivedi, V.D. and Chavan, P.R.
Indian Journal of Medical Research. 2011; 134(10): 458-462
[Pubmed]  [Google Scholar]
7 Prostate biopsy findings in Indian men: A hospital-based study
Sinha, S. and Siriguri, S.R. and Kanakmedala, S.K. and Bikkasani, K.
Indian Journal of Cancer. 2011; 48(2): 175-180
[Pubmed]  [Google Scholar]
8 Genetic variants in the distal enhancer region of the PSA gene and their implication in the occurrence of advanced prostate cancer
Chavan, S.V. and Maitra, A. and Roy, N. and Patwardhan, S. and Chavan, P.R.
Molecular Medicine Reports. 2010; 3(5): 837-843
[Pubmed]  [Google Scholar]
9 Cut-off value for PSA: Do we need a change
Singh, J.C.
Journal of Postgraduate Medicine. 2009; 55(2): 150-151
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow